|
|
Incorporated in 2006, ANG Lifesciences India Limited is a pharmaceutical company whose engaged in the business of manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials in India.
Company's products include sterile dry powder vials for anti-biotics, anti-ulcerant, glucocorticoid and anti-inflammatory, anti-malarial, and anesthetic. It manufactures products in compliance with GMP requirements.
However, Company that currently operates at an average capacity utilization of 70% for last two fiscals hopes to achieve 90% plus in coming years. ANGL is likely to consider acquisition options as well to enhance its manufacturing capacities. Its customer list includes Wockhardt, DHS Maharashtra, Global Hospitals, Elder, Emcure, BPPI, Govt. of Haryana, Hetero Healthcare etc.
The object of the issue are:
1. To meet the working capital requirement;
2. To meet the expenses of the Issue.
| IPO Date | Aug 29, 2017 to Aug 31, 2017 |
| Listing Date | Friday, September 8, 2017 |
| Face Value | ₹10 per share |
| Price | ₹80 per share |
| Lot Size | 1600 Shares |
| Issue Size | 1,500,800 shares of ₹10 (aggregating up to ₹12.01 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Company Promoters | The promoters of the company are: 1. Rajesh Gupta |
The ANG Lifesciences IPO lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹128,000).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹128,000 |
| Retail (Max) | 1 | 1600 | ₹128,000 |
Investors may consider investment for medium to long term in ANG Lifesciences BSE SME IPO. Read detail review...
The ANG Lifesciences IPO is subscribed times on Aug 31, 2017 5:00:00 PM. The public issue subscribed times in the retail category, times in the QIB category, and times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| NII | |
| Retail | |
| Total |
| Listing Date | Friday, September 8, 2017 |
| BSE Script Code | 540694 |
| NSE Symbol | |
| Listing In | M Group of Securities |
| ISIN | INE236W01016 |
| IPO Price | ₹80 per share |
| Face Value | ₹10 per share |
|
|
ANG Lifesciences India Ltd
Darbara Complex SCO 113 I Flr,
Dist. Shopping Centre B Block,
Amritsar - 143001
Phone: +91-0183-5070118
Email: cs@anglifesciences.com
Website: http://www.anglifesciences.com
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com
ANG Lifesciences IPO is a SME IPO of 1,500,800 equity shares of the face value of ₹10 aggregating up to ₹12.01 Crores. The issue is priced at ₹80 per share. The minimum order quantity is 1600 Shares.
The IPO opens on Aug 29, 2017, and closes on Aug 31, 2017.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
The ANG Lifesciences IPO opens on Aug 29, 2017 and closes on Aug 31, 2017.
ANG Lifesciences IPO lot size is 1600 Shares and the minimum order quantity is .
You can apply in ANG Lifesciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for ANG Lifesciences IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the ANG Lifesciences IPO allotment status.
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
Top Contributor (400+ Posts, 400+ Likes)
